Finoriq research workspace
ARTIVION, INC. (AORT) SEC Filings & Filing Highlights
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human. Review AORT SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.
- Company
- ARTIVION, INC. (AORT)
- Ticker
- AORT
- Market Cap
- $1.2B
- Latest Price
- $25.65
- Industry
- Medical Devices
ARTIVION, INC. (AORT) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ARTIVION, INC. (AORT).
| Event | Form | Date |
|---|---|---|
| Gilmartin Group LLCArtivion Completes Acquisition of Endospan Ltd | 8-K8.01 | 2026-05-18 |
| Gilmartin Group LLCArtivion Completes Acquisition of Endospan Ltd | 8-K7.01 | 2026-05-18 |
| The final results of the voting on each matter of business at the Annual Meeting are as followsAt Artivion, Inc.’s (the “Company” or “Artivion”) 2026 Annual Meeting of Stockholders held on May 12, 2026 (the “Annual Meeting”), Artivion... | 8-K5.07 | 2026-05-15 |
| Gilmartin Group LLCArtivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan | 8-K2.02 | 2026-05-07 |
| Securities Purchase Option AgreementAs previously disclosed in connection with the announcement of the Exclusive Distribution Agreement, dated September 11, 2019, between JOTE... | 8-K1.01 | 2026-05-07 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.